MCK News Alert Mckesson Corp (MCK) 209.79 12/25/2014 19:54:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mckesson Corp (MCK) 209.79 $MCK

Quality Systems' Organic Growth to be Hurt by Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 1:00PM CST
On Dec 18, we issued an updated research report on Quality Systems Inc. (QSII). We remain optimistic owing to continued strength in the company's NextGen division as well as the expected benefit from its Mirth acquisition.
MCK: 209.79 (+0.58), QSII: 15.73 (+0.23), MDRX: 12.87 (-0.13), ATHN: 149.72 (-1.78)

3 Reasons Rite Aid Corporation's Stock Could Soar in 2015
Keith Speights, The Motley Fool - Motley Fool - Mon Dec 22, 7:02AM CST
Rite Aid Corporation shareholders can celebrate big gains of more than 30% for 2015 headed into the last few days of the year thanks in part to a blow-out third quarter. However, some investors might still be disappointed. Why? Because the stock of...
MCK: 209.79 (+0.58), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

An Important Takeaway From Rite Aid's Earnings
Brian Nichols - at Seeking Alpha - Fri Dec 19, 2:50PM CST

MCK: 209.79 (+0.58), RAD: 7.26 (-0.09)

MedAssets to Boost Advisory Solutions with New Offering - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 4:58PM CST
Provider of technology-enabled products and services for hospitals, MedAssets, Inc. (MDAS), recently announced that the company's Advisory Solutions enterprise consulting group will now offer Physician Compensation Alignment services.
MCK: 209.79 (+0.58), MDAS: 19.96 (+0.23), PINC: 33.60 (+0.12), ATHN: 149.72 (-1.78)

McKesson Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Dec 18, 3:10PM CST
McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco at 10:00 a.m. PT on Tuesday, January 13, 2015. Audio webcasts will be available live and archived on the company's Investor Relations website at http://investor.mckesson.com. A complete listing of upcoming events for the investment community is available on the company's Investor Relations website.
MCK: 209.79 (+0.58), JPM: 62.48 (unch)

Rite Aid Corporation Delivers A Huge Win
Todd Campbell, The Motley Fool - Motley Fool - Thu Dec 18, 1:21PM CST
Source: Rite Aid Corporation The first two fiscal quarters of 2014 were  downright dismal for Rite Aid Corporation investors. Rite Aid's failure to deliver cost savings from its new drug purchasing and distribution deal with McKesson and its...
MCK: 209.79 (+0.58), RAD: 7.26 (-0.09)

SmarTrend Watching for Potential Rebound in Shares of McKesson After 2.41% Loss
Comtex SmarTrend(R) - Tue Dec 16, 5:35PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $201.31 to a high of $208.10. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $204.80 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 209.79 (+0.58)

After Yesterday's Decline of 2.41%, McKesson Offers Investors Better Value
Comtex SmarTrend(R) - Tue Dec 16, 5:35PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $201.31 to a high of $208.10. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $204.80 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 209.79 (+0.58)

Water-Logged And Getting Wetter: McKesson (MCK)
at The Street - Tue Dec 16, 3:14PM CST
Trade-Ideas LLC identified McKesson (MCK) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
MCK: 209.79 (+0.58)

Jim Cramer: These Charts Prove It's Oil-and-Gas vs. Everything Else
at The Street - Tue Dec 16, 10:01AM CST
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
CAH: 82.07 (+0.15), WMT: 86.43 (-0.23), PDCO: 48.79 (-0.02), JACK: 78.82 (-0.17), CFR: 70.74 (+0.17), RCL: 82.36 (+0.16), TGT: 74.65 (-0.04), LOW: 67.51 (-0.43), MSFT: 48.14 (-0.31), HSIC: 137.87 (+0.15), REGN: 400.12 (+6.07), YUM: 72.79 (+0.11), SYK: 96.00 (-0.61), MU: 34.91 (-0.06), BCR: 169.10 (-0.44), MCK: 209.79 (+0.58), STX: 68.82 (+0.17), EW: 130.75 (+1.17), WLP: 128.71 (+0.94), UAL: 64.93 (+2.45), CELG: 109.60 (+3.48), CBRL: 138.16 (+0.46), AZO: 617.43 (-3.87), STE: 66.76 (+0.85), MRK: 57.46 (+0.25), MCD: 93.83 (-0.39), SHW: 264.55 (+1.46), BIIB: 340.89 (+5.13), BDX: 139.90 (+1.44), BMRN: 88.18 (+0.89), CCL: 45.39 (+0.09), MDT: 74.08 (+0.31), SNA: 139.09 (unch), JBLU: 15.50 (+0.21), ADBE: 74.74 (+0.36), HUM: 144.38 (-0.31), RFMD: 16.59 (+0.29), EBAY: 57.10 (-0.12), DPZ: 95.39 (-0.23), SRCL: 133.27 (-0.16), XLF: 24.95 (-0.04), ZMH: 114.11 (+0.64), CY: 14.61 (+0.26), HD: 103.56 (-0.20), ORLY: 193.95 (-1.11), DIS: 94.42 (-0.27), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), WDC: 113.11 (-0.18), PLKI: 55.50 (+0.01), HPQ: 40.54 (+0.18), FRGI: 56.97 (+0.47), DIN: 101.87 (-0.40), DRI: 58.42 (-0.09), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), TJX: 67.87 (-0.25), JWN: 78.14 (-0.58), AVGO: 100.72 (-0.06)


Family of executed Ohio inmate sues expert witness
By ANDREW WELSH-HUGGINS - AP - Tue Dec 16, 9:36AM CST
COLUMBUS, Ohio (AP) — The state's former expert witness on lethal injection should have known that a condemned inmate would suffer because of a two-drug combo that had never been used before, the inmate's family said in a lawsuit.
MCK: 209.79 (+0.58), HSP: 62.60 (-0.07)

2015 Healthcare Sector Predictions
Leonard Yaffe - Seeking Alpha - Tue Dec 16, 5:50AM CST
Below, I shall review my 2013 and 2014 predictions, as well as share my thoughts on the year ahead. Below are my 2014 Predictions: 1. An increase (however modest) of those without prior health insurance, combined with an improving economy, will...
HYH: 42.62 (-0.24), ABT: 45.70 (-0.02), BIIB: 340.89 (+5.13), MCK: 209.79 (+0.58), CAH: 82.07 (+0.15), DPLO: 29.90 (+0.49), PFE: 31.42 (-0.03), KMB: 117.77 (-0.21), HSP: 62.60 (-0.07), CELG: 109.60 (+3.48), JNJ: 104.59 (+0.31), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), CVS: 97.89 (+0.02), AGIO: 109.67 (+2.45), REGN: 400.12 (+6.07)

McKesson starts venture fund
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 12:21PM CST

MCK: 209.79 (+0.58)

McKesson Launches Venture Fund, Appoints Tom Rodgers as Managing Director
Business Wire - Wed Dec 10, 7:30AM CST
McKesson Corporation (NYSE:MCK) today announced that it has launched McKesson Ventures, a strategic venture capital fund, to invest in early and growth stage companies addressing both current and emerging business challenges facing the healthcare industry. Industry veteran Tom Rodgers has joined McKesson Ventures as managing director and leads the fund's investment portfolio.
MCK: 209.79 (+0.58)

McKesson Set to Possibly Rebound After Yesterday's Selloff of 1.17%
Comtex SmarTrend(R) - Tue Dec 09, 3:56PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $208.36 to a high of $212.78. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $209.90 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 209.79 (+0.58)

After Yesterday's Decline of 1.17%, McKesson Offers Investors Better Value
Comtex SmarTrend(R) - Tue Dec 09, 3:56PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $208.36 to a high of $212.78. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $209.90 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 209.79 (+0.58)

Will Rite Aid Corp's Earnings Cause Shares to Pop (or Drop)?
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 09, 8:05AM CST
Source: Wiki Commons user Specious After a stellar 2013 during which shares soared 272%, Rite Aid 's stock has tumbled more than 33% from its peak above $8 in May. That drop is due to two consecutive and uninspiring earnings reports that...
MCK: 209.79 (+0.58), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09)

Omnicare Rewards Shareholders with 10% Dividend Raise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 4:50PM CST
Healthcare services company, Omnicare (OCR), recently raised its quarterly dividend by 10% to 22 cents per share.
PMC: 20.76 (-0.13), OCR: 73.20 (+0.33), MCK: 209.79 (+0.58), CAH: 82.07 (+0.15)

'Overdue' Dividend Increases (And Other Streaks At Risk)
David Fish - at Seeking Alpha - Sun Dec 07, 5:01PM CST

ASH: 119.40 (-0.48), SJR: 27.15 (+0.14), CAG: 36.86 (-0.07), UTX: 116.91 (-0.30), PSA: 187.43 (-1.18), BOBE: 50.58 (-0.04), CAE: 13.12 (+0.10), COH: 36.97 (-0.23), FAST: 47.87 (+0.15), MOCO: 17.10 (-0.84), AMAT: 25.25 (-0.15), ORIT: 15.21 (-0.02), CHS: 16.12 (+0.07), MCK: 209.79 (+0.58), PETS: 14.23 (+0.08), UBSI: 36.64 (-0.18), WTI: 7.55 (-0.12), TGH: 34.59 (-0.35), ORCL: 46.23 (+0.22), DRI: 58.42 (-0.09), WABC: 48.76 (-0.30), ESV: 30.39 (-0.89), HCI: 45.48 (-0.09), NAUH: 2.93 (+0.11), CLMT: 22.15 (-0.08), PETM: 81.16 (+0.03)

Global Operating Room Management (Data Management, Anesthesia, Surgical, Performance) Market - Forecast to 2019
PR Newswire Europe - Wed Dec 03, 11:52AM CST
Research and Markets [http://www.researchandmarkets.com/research/kmf6js/diabetes////////////////////////////////////////////////////////////////t_blank] has announced the addition of the "Operating Room Management Market by Product, Application, Component, Delivery Mode - Global Forecast to 2019" [http://www.researchandmarkets.com/research/hv4293/operating_room] report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 [http://photos.prnewswire.com/prnh/20130307/600769]
MCK: 209.79 (+0.58), CERN: 65.10 (-0.21)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 337

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 296

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 195

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 271

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Mesirow Recognized Among Top Money Management Workplaces Again

Updated Category News Views 156

Mesirow's Remarkable Recognition in Money Management Mesirow has just been honored by Pensions & Investments as a Best Places to Work in Money Management for the year 2025, marking the seventh occasion the firm has received this prestigious recognition. This accolade reflects Mesirow's unwavering commitment to fostering a workplace that prioritizes culture, employee...

Continue Reading
Follett and Bath & Body Works Team Up for Campus Retail Revolution

Updated Category News Views 275

Follett Higher Education Partners with Bath & Body Works This happy collaboration marks Follett Higher Education's new venture to enrich student life on college campuses across the nation. Follett, recognized as North America's largest campus retailer, is working with Bath & Body Works to bring their beloved bath and body products directly to students at more than 150...

Continue Reading
Understanding Recent Share Transactions of Planisware SA

Updated Category News Views 125

Overview of Planisware's Recent Share Transactions Planisware SA has recently undergone several notable transactions concerning its own shares. As a leader in project portfolio management software, the company's activities on the share market reflect its strong position and proactive approach in satisfying investor interests. Company Details Planisware SA is widely...

Continue Reading
Investor Alert: Lawsuit Against Iris Energy Limited Explained

Updated Category News Views 112

Overview of the Investor Lawsuit Against Iris Energy Limited The legal landscape for investors can often be complex, especially when serious allegations are involved. Recently, the national securities law firm, Faruqi & Faruqi, LLP, has initiated an investigation targeting Iris Energy Limited (NASDAQ: IREN) concerning potential securities law violations. The firm is...

Continue Reading
Warner Bros. Discovery Welcomes Anton Levy to Board

Updated Category News Views 166

Warner Bros. Discovery Welcomes Anton Levy to the Board Warner Bros. Discovery, Inc. (NASDAQ: WBD) is thrilled to announce the upcoming addition of Anton Levy to its Board of Directors as an independent member. This decision is part of the company's commitment to building a strong leadership team aimed at navigating the evolving media landscape. Anton Levy: A Wealth of...

Continue Reading